Detalhe da pesquisa
1.
Evolutionary trajectories of small cell lung cancer under therapy.
Nature
; 627(8005): 880-889, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480884
2.
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
N Engl J Med
; 389(22): 2063-2075, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861218
3.
Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
Eur Respir J
; 61(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180086
4.
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 125(26): 4024-31, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887777
5.
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
JTO Clin Res Rep
; 5(4): 100626, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586301
6.
Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy.
Front Immunol
; 14: 1261070, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942314
7.
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study.
J Clin Oncol
; 41(16): 2893-2903, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689692
8.
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Immunotherapy
; 13(2): 125-141, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172323
9.
Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab.
Blood Adv
; 3(16): 2491-2498, 2019 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31451445
10.
Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cells.
J Gen Virol
; 90(Pt 3): 693-701, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19218216